# Anticancer Activity of Microbial Biosurfactants Amphisin and Viscosinamide Against Melanoma Cells

**Authors:** Dominika Jama, Zbigniew Lazar, Tomasz Janek

PMC · DOI: 10.3390/molecules31040668 · Molecules · 2026-02-14

## TL;DR

This study shows that two microbial biosurfactants, amphisin and viscosinamide, can selectively kill melanoma cells while sparing normal cells.

## Contribution

The novel finding is that amphisin and viscosinamide exhibit selective antitumor activity against melanoma cells via membrane damage and apoptosis.

## Key findings

- Viscosinamide showed stronger cytotoxic activity than amphisin against melanoma cells.
- Both compounds induced apoptosis through membrane damage and activation of the intrinsic mitochondrial pathway.
- The compounds effectively inhibited melanoma cell migration.

## Abstract

The anticancer activity of two novel microbial lipopeptide biosurfactants, amphisin and viscosinamide, was evaluated against human (A375) and murine (B16 4A5) melanoma cells. Normal human dermal fibroblasts (NHDFs) were used as a control. Cell viability was assessed using the MTT assay, while membrane integrity was analysed by the lactate dehydrogenase (LDH) release test. Early and late stages of apoptosis were investigated using Annexin V-FITC and Hoechst 33342 staining, respectively. In addition, the expression of apoptosis-related genes bax and bcl-2 was quantified by RT-qPCR. Finally, the wound healing (scratch) assay was performed to evaluate the effect of the tested lipopeptides on the migratory ability of melanoma cells. Both lipopeptides inhibited melanoma cell proliferation in a concentration- and time-dependent manner and exhibited significantly lower cytotoxicity toward NHDF cells, indicating selective antitumor activity. Viscosinamide exhibited stronger cytotoxic activity than amphisin. LDH release and fluorescence microscopy confirmed that the main mechanism of cytotoxicity was cell membrane damage and induction of apoptosis, including phosphatidylserine externalization and characteristic changes in the cell nucleus, such as chromatin condensation and cell nucleus fragmentation. Gene expression analysis demonstrated increased levels of bax and decreased levels of bcl-2, indicating activation of the intrinsic mitochondrial pathway of apoptosis. In addition, tested compounds effectively inhibited cell migration. The studies show that amphisin and viscosinamide exhibit selective anticancer potential related to the cell membrane and are promising molecules for further development as melanoma treatments.

## Linked entities

- **Genes:** BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596]
- **Chemicals:** viscosinamide (PubChem CID 134128301)
- **Diseases:** melanoma (MONDO:0005105)
- **Species:** Homo sapiens (taxon 9606), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, Bax (BCL2-associated X protein) [NCBI Gene 12028]
- **Diseases:** necrosis (MESH:D009336), breast cancer (MESH:D001943), Cytotoxicity (MESH:D064420), metastasis (MESH:D009362), colon cancer (MESH:D015179), hemolytic (MESH:D006461), skin cancer (MESH:D012878), Cancer (MESH:D009369), Melanoma (MESH:D008545), injury to (MESH:D014947)
- **Chemicals:** CO2 (MESH:D002245), Lipopeptides (MESH:D055666), L-glutamine (MESH:D005973), Amphisin (MESH:C438267), lipid (MESH:D008055), Hoechst 33342 (MESH:C017807), MTT (MESH:C070243), Viscosinamide (MESH:C121478), Phosphatidylserine (MESH:D010718), surfactin C (MESH:C009365), (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MESH:C022616), Biosurfactants (-), penicillin (MESH:D010406), glycolipid (MESH:D006017), alpha-MEM (MESH:C420642), Hoechst 33258 (MESH:D006690), water (MESH:D014867), Staurosporine (MESH:D019311), Ile (MESH:D007532), streptomycin (MESH:D013307), acetonitrile (MESH:C032159), Triton X-100 (MESH:D017830), dacarbazine (MESH:D003606)
- **Species:** Pseudomonas (RNA similarity group I, genus) [taxon 286], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Bacillus subtilis (species) [taxon 1423]
- **Cell lines:** A375 — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_0132), NHDF — Homo sapiens (Human), Finite cell line (CVCL_UF42), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), LoVo — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0399), B16-F10 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0159), B16 4A5 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_4612)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942773/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942773/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942773/full.md

---
Source: https://tomesphere.com/paper/PMC12942773